Business

DOCM: Strong Rx and digital growth, margin expansion, and Google partnership set up 2026 EBITDA breakeven

DOCM: Strong Rx and digital growth, margin expansion, and Google partnership set up 2026 EBITDA breakeven

Docmorris LtdMarch 19, 20263
DOCM: Strong Rx and digital growth, margin expansion, and Google partnership set up 2026 EBITDA breakeven

About this update from Docmorris Ltd

Revenue grew 11.1% in 2025, driven by Rx (+33%) and digital services (+110%), with strong margin gains and a robust liquidity position. EBITDA breakeven is targeted for 2026, supported by platform expansion, cost control, and a new Google partnership. Based on This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Docmorris Ltd

More from Docmorris Ltd

All Docmorris Ltd news →